InvestorsHub Logo
Followers 42
Posts 12463
Boards Moderated 0
Alias Born 11/18/2016

Re: Simple Steve post# 56089

Thursday, 02/22/2018 12:03:00 PM

Thursday, February 22, 2018 12:03:00 PM

Post# of 108192
Steve, BPs enter into licensing deals for products at all stages of development. Look at Amgen for pre-clinical NEO. The fact that AXAL is up for EMA approval is a big plus for a BP. However, the price also goes up. I’m sure that the price has been the sticking point thus far. Good. Don’t give it away cheap.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News